Retinoblastoma

Results: 102



#Item
11Objectives Upon completion of BCSC Section 4, Ophthalmic Pathology and Intraocular Tumors, the reader should be able to • describe a structured approach to understanding major ocular conditions based on a hierarchical

Objectives Upon completion of BCSC Section 4, Ophthalmic Pathology and Intraocular Tumors, the reader should be able to • describe a structured approach to understanding major ocular conditions based on a hierarchical

Add to Reading List

Source URL: store.aao.org

Language: English - Date: 2014-05-14 17:01:32
12SSppoonnssoorreedd bbyy AAbbbbootttt LLaabboorraattoorriieess LLiim miitteedd The 15th International Society for Genetic Eye Disease and the 12th International Retinoblastoma Symposium, September 1-3, 2005

SSppoonnssoorreedd bbyy AAbbbbootttt LLaabboorraattoorriieess LLiim miitteedd The 15th International Society for Genetic Eye Disease and the 12th International Retinoblastoma Symposium, September 1-3, 2005

Add to Reading List

Source URL: www.medicine.org.hk

Language: English - Date: 2006-01-09 03:17:40
13Complex effects of flavopiridol on the expression of primary response genes

Complex effects of flavopiridol on the expression of primary response genes

Add to Reading List

Source URL: www.celldiv.com

Language: English
14Single-cell E2F Dynamics Reveal the Control Logic of Cell Cycle Entry Peng Dong1, Manoj V. Maddali2, Jaydeep K. Srimani2, Bernard Mathey-Prevot3 and Lingchong You4 Short Abstract — To explore the molecular events respo

Single-cell E2F Dynamics Reveal the Control Logic of Cell Cycle Entry Peng Dong1, Manoj V. Maddali2, Jaydeep K. Srimani2, Bernard Mathey-Prevot3 and Lingchong You4 Short Abstract — To explore the molecular events respo

Add to Reading List

Source URL: q-bio.org

Language: English - Date: 2013-07-16 19:07:14
15Cell Division BioMed Central Open Access

Cell Division BioMed Central Open Access

Add to Reading List

Source URL: www.celldiv.com

Language: English
16Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec

Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec

Add to Reading List

Source URL: astx.com

Language: English
17TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex

TIGAR induces p53-mediated cell-cycle arrest by regulation of RB–E2F1 complex

Add to Reading List

Source URL: www.altogen.com

Language: English - Date: 2014-12-16 13:49:08
18“Red flags” Warning signs of cancer in children Cancer in children is rare and potentially curable in over 70 per cent of patients. Early diagnosis is important, particularly with solid tumours where, in most cases,

“Red flags” Warning signs of cancer in children Cancer in children is rare and potentially curable in over 70 per cent of patients. Early diagnosis is important, particularly with solid tumours where, in most cases,

Add to Reading List

Source URL: www.cancer.org.au

Language: English - Date: 2014-07-04 02:49:46
19Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment 1

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Paediatric Cancer Treatment 1

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-24 06:46:39
20Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Teenage and Young Adult Cancer Treatment Clinical Commissioning Policy: Proton Beam

Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Teenage and Young Adult Cancer Treatment Clinical Commissioning Policy: Proton Beam

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-23 14:10:41